These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 37402332

  • 1. The inflammatory oxidant peroxynitrous acid modulates the structure and function of the recombinant human V3 isoform of the extracellular matrix proteoglycan versican.
    Jørgensen SM, Lorentzen LG, Hammer A, Hoefler G, Malle E, Chuang CY, Davies MJ.
    Redox Biol; 2023 Aug; 64():102794. PubMed ID: 37402332
    [Abstract] [Full Text] [Related]

  • 2. Peroxynitrous acid-modified extracellular matrix alters gene and protein expression in human coronary artery smooth muscle cells and induces a pro-inflammatory phenotype.
    Jørgensen SM, Lorentzen LG, Chuang CY, Davies MJ.
    Free Radic Biol Med; 2022 Jun; 186():43-52. PubMed ID: 35526806
    [Abstract] [Full Text] [Related]

  • 3. Identification and quantification of protein nitration sites in human coronary artery smooth muscle cells in the absence and presence of peroxynitrous acid/peroxynitrite.
    Xu S, Chuang CY, Hawkins CL, Hägglund P, Davies MJ.
    Redox Biol; 2023 Aug; 64():102799. PubMed ID: 37413764
    [Abstract] [Full Text] [Related]

  • 4. Exposure of tropoelastin to peroxynitrous acid gives high yields of nitrated tyrosine residues, di-tyrosine cross-links and altered protein structure and function.
    Degendorfer G, Chuang CY, Mariotti M, Hammer A, Hoefler G, Hägglund P, Malle E, Wise SG, Davies MJ.
    Free Radic Biol Med; 2018 Feb 01; 115():219-231. PubMed ID: 29191462
    [Abstract] [Full Text] [Related]

  • 5. Cross-linking and modification of fibronectin by peroxynitrous acid: Mapping and quantification of damage provides a new model for domain interactions.
    Mariotti M, Rogowska-Wrzesinska A, Hägglund P, Davies MJ.
    J Biol Chem; 2021 Feb 01; 296():100360. PubMed ID: 33539924
    [Abstract] [Full Text] [Related]

  • 6. Identification and quantification of sites of nitration and oxidation in the key matrix protein laminin and the structural consequences of these modifications.
    Lorentzen LG, Chuang CY, Rogowska-Wrzesinska A, Davies MJ.
    Redox Biol; 2019 Jun 01; 24():101226. PubMed ID: 31154162
    [Abstract] [Full Text] [Related]

  • 7. Peroxynitrite-mediated oxidation of plasma fibronectin.
    Degendorfer G, Chuang CY, Kawasaki H, Hammer A, Malle E, Yamakura F, Davies MJ.
    Free Radic Biol Med; 2016 Aug 01; 97():602-615. PubMed ID: 27396946
    [Abstract] [Full Text] [Related]

  • 8. Peroxynitrous acid induces structural and functional modifications to basement membranes and its key component, laminin.
    Degendorfer G, Chuang CY, Hammer A, Malle E, Davies MJ.
    Free Radic Biol Med; 2015 Dec 01; 89():721-33. PubMed ID: 26453917
    [Abstract] [Full Text] [Related]

  • 9. Degradation of matrix glycosaminoglycans by peroxynitrite/peroxynitrous acid: evidence for a hydroxyl-radical-like mechanism.
    Kennett EC, Davies MJ.
    Free Radic Biol Med; 2007 Apr 15; 42(8):1278-89. PubMed ID: 17382208
    [Abstract] [Full Text] [Related]

  • 10. Exposure to peroxynitrite impacts the ability of anastellin to modulate the structure of extracellular matrix.
    He J, Chuang CY, Hawkins CL, Davies MJ, Hägglund P.
    Free Radic Biol Med; 2023 Sep 15; 206():83-93. PubMed ID: 37385567
    [Abstract] [Full Text] [Related]

  • 11. V3: an enigmatic isoform of the proteoglycan versican.
    Wight TN, Day AJ, Kang I, Harten IA, Kaber G, Briggs DC, Braun KR, Lemire JM, Kinsella MG, Hinek A, Merrilees MJ.
    Am J Physiol Cell Physiol; 2023 Aug 01; 325(2):C519-C537. PubMed ID: 37399500
    [Abstract] [Full Text] [Related]

  • 12. Versican and the control of inflammation.
    Wight TN, Kang I, Merrilees MJ.
    Matrix Biol; 2014 Apr 01; 35():152-61. PubMed ID: 24513039
    [Abstract] [Full Text] [Related]

  • 13. Versican/PG-M Assembles Hyaluronan into Extracellular Matrix and Inhibits CD44-mediated Signaling toward Premature Senescence in Embryonic Fibroblasts.
    Suwan K, Choocheep K, Hatano S, Kongtawelert P, Kimata K, Watanabe H.
    J Biol Chem; 2009 Mar 27; 284(13):8596-604. PubMed ID: 19164294
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Versican V1 isoform regulates cell-associated matrix formation and cell behavior differentially from aggrecan in Swarm rat chondrosarcoma cells.
    Wasa J, Nishida Y, Shinomura T, Isogai Z, Futamura N, Urakawa H, Arai E, Kozawa E, Tsukushi S, Ishiguro N.
    Int J Cancer; 2012 May 15; 130(10):2271-81. PubMed ID: 21671478
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The versican-hyaluronan complex provides an essential extracellular matrix niche for Flk1+ hematoendothelial progenitors.
    Nandadasa S, O'Donnell A, Murao A, Yamaguchi Y, Midura RJ, Olson L, Apte SS.
    Matrix Biol; 2021 Mar 15; 97():40-57. PubMed ID: 33454424
    [Abstract] [Full Text] [Related]

  • 19. Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration.
    Evanko SP, Potter-Perigo S, Bollyky PL, Nepom GT, Wight TN.
    Matrix Biol; 2012 Mar 15; 31(2):90-100. PubMed ID: 22155153
    [Abstract] [Full Text] [Related]

  • 20. V3 versican isoform alters the behavior of human melanoma cells by interfering with CD44/ErbB-dependent signaling.
    Hernández D, Miquel-Serra L, Docampo MJ, Marco-Ramell A, Cabrera J, Fabra A, Bassols A.
    J Biol Chem; 2011 Jan 14; 286(2):1475-85. PubMed ID: 21078678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.